Tempus, a precision oncology company, provides physicians with genomic sequencing and molecular analysis services. In the past year, leading hospitals such as Cleveland Clinic, Rochester, Minn.-based Mayo Clinic and University of Chicago Medicine have partnered with Tempus as part of their cancer care programs.
The app, dubbed Tempus Labs, is available on Apple’s App Store and the Google Play store for physicians who order one of the company’s genomic sequencing services. The app provides access to a patient’s report, clinical information, molecular alterations, potential therapies and relevant clinical trial options.
“We live in a mobile society where people have access to incredible amounts of data at their fingertips every day,” Eric Lefkofsky, founder and CEO of Tempus, said in a news release. “Our new app is a big step in the right direction to bring some of the advantages of that technology to physicians as they treat patients.”
More articles on data analytics and precision medicine:
23andMe is hiring — 3 suggestions about the company’s growth
Meharry Medical College launches data science institute to improve care in minority populations
Ascension, Banner Health among 6 newest hospitals to join Syapse’s precision oncology network
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
